A pilot study of inhaled nitric oxide in preterm infants treated with nasal continuous positive airway pressure for respiratory distress syndrome

Intensive Care Medicine

Volumn 31, Issue 7, 2005, Pages 959-964

  Lindwall, Robert ^a   Blennow, Mats ^b   Svensson, Mats ^a   Jonsson, Baldvin ^b   Berggren Boström, Eva ^b   Flanby, Martino ^b   Lönnqvist, Per Arne ^b   Frostell, Claes ^a   Norman, Mikael ^b  

^a DANDERYD HOSPITAL   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Administration, inhalation; Continuous positive airway pressure; Nitric oxide; Respiratory distress syndrome, newborn

Indexed keywords

METHEMOGLOBIN; NITRIC OXIDE; NITROGEN;

ARTERIAL OXYGEN TENSION; ARTICLE; BIRTH WEIGHT; BLOOD PRESSURE; BREATHING PATTERN; BREATHING RATE; CARBON DIOXIDE BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FOLLOW UP; GAS EXCHANGE; HEART RATE; HUMAN; INFANT; LUNG ALVEOLUS OXYGEN TENSION; MORBIDITY; OXYGENATION; PERINATAL PERIOD; POSITIVE END EXPIRATORY PRESSURE; PREMATURITY; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY DISTRESS SYNDROME; STATISTICAL SIGNIFICANCE; UNIVERSITY HOSPITAL;

ADMINISTRATION, INHALATION; BLOOD PRESSURE; BRONCHODILATOR AGENTS; CONTINUOUS POSITIVE AIRWAY PRESSURE; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INTENSIVE CARE UNITS, NEONATAL; NITRIC OXIDE; PILOT PROJECTS; RESPIRATORY DISTRESS SYNDROME, NEWBORN;

EID: 21744442748     PISSN: 03424642     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00134-005-2593-5     Document Type: Article

References (37)

1. Clark RH, Kueser TJ, Walker MW, Southgate WM, Huckaby JL, Perez JA, Roy BJ, Keszler M, Kinsella JP (2000) Low-dose nitric oxide therapy for persistent pulmonary hypertension of the newborn. Clinical Inhaled Nitric Oxide Research Group. N Engl J Med 342:469-474
2. Neonatal Inhaled Nitric Oxide Study Group (1997) Inhaled nitric oxide in full-term and nearly full-term infants with hypoxic respiratory failure. N Engl J Med 336:597-604
3. Macrae DJ, Field D, Mercier JC, Moller J, Stiris T, Biban P, Cornick P, Goldman A, Gothberg S, Gustafsson LE, Hammer J, Lonnqvist PA, Sanchez-Luna M, Sedin G, Subhedar N (2004) Inhaled nitric oxide therapy in neonates and children: reaching a European consensus. Intensive Care Med 30:372-380
4. Kinsella JP, Parker TA, Galan H, Sheridan BC, Halbower AC, Abman SH (1997) Effects of inhaled nitric oxide on pulmonary edema and lung neutrophil accumulation in severe experimental hyaline membrane disease. Pediatr Res 41:457-463
5. Sato Y, Walley KR, Klut ME, English D, D'yachkova Y, Hogg JC, van Eeden SF (1999) Nitric oxide reduces the sequestration of polymorphonuclear leukocytes in lung by changing deformability and CD18 expression. Am J Respir Crit Care Med 159:1469-1476
6. Mattsson EJ, Geary RL, Kraiss LW, Vergel S, Liao JK, Corson MA, Au YP, Hanson SR, Clowes AW (1998) Is smooth muscle growth in primate arteries regulated by endothelial nitric oxide synthase? J Vasc Surg 28:514-521
7. Sarkar R, Webb RC (1998) Does nitric oxide regulate smooth muscle cell proliferation? A critical appraisal. J Vasc Res 35:135-142
8. Tang JR, Markham NE, Lin YJ, McMurtry IF, Maxey A, Kinsella JP, Abman SH (2004) Inhaled nitric oxide attenuates pulmonary hypertension and improves lung growth in infant rats after neonatal treatment with a VEGF receptor inhibitor. Am J Physiol Lung Cell Mol Physiol 287:L344-L351
9. Lim DG, Sweeney S, Bloodsworth A, White CR, Chumley PH, Krishna NR, Schopfer F, O'Donnell VB, Eiserich JP, Freeman BA (2002) Nitrolinoleate, a nitric oxide-derived mediator of cell function: synthesis, characterization, and vasomotor activity. Proc Natl Acad Sci USA 99:15941-15946
10. Stamler JS, Lamas S, Fang FC (2001) Nitrosylation. the prototypic redox-based signaling mechanism. Cell 106:675-683
11. Lecour S, Clermont G, du Toit E, Gilson L, Maupoil V, Lowe S, Dupuis P, Girard C, Rochette L (2003) Evidence for the extrapulmonary localization of inhaled nitric oxide. Heart Dis 5:372-377
12. Takagawa Y, Ura N, Nanba M, Agata J, Higashiura K, Torii T, Takada M, Shimamoto K (1999) The contribution of nitric oxide to diuretic and natriuretic effects of renal kinins in normotensive rats. Hypertens Res 22:129-134
13. Wraight WM, Young JD (2001) Renal effects of inhaled nitric oxide in humans. Br J Anaesth 86:267-269
14. Van Marter LJ, Allred EN, Pagano M, Sanocka U, Parad R, Moore M, Susser M, Paneth N, Leviton A (2000) Do clinical markers of barotrauma and oxygen toxicity explain interhospital variation in rates of chronic lung disease? The Neonatology Committee for the Developmental Network. Pediatrics 105:1194-1201
15. Lindwall R, Frostell CG, Lonnqvist PA (2002) Delivery characteristics of a combined nitric oxide nasal continuous positive airway pressure system. Paediatr Anaesth 12:530-536
16. Putensen C, Rasanen J, Lopez FA, Downs JB (1994) Continuous positive airway pressure modulates effect of inhaled nitric oxide on the ventilation-perfusion distributions in canine lung injury. Chest 106:1563-1569
17. Schreiber MD, Gin-Mestan K, Marks JD, Huo D, Lee G, Srisuparp P (2003) Inhaled nitric oxide in premature infants with the respiratory distress syndrome. N Engl J Med 349:2099-2107
18. Zhao DH, Sun B, Wu ZH, Lindwall R, Robertson B (2000) Mitigation of endotoxin-induced acute lung injury in ventilated rabbits by surfactant and inhaled nitric oxide. Intensive Care Med 26:229-238
19. Zhu GF, Sun B, Niu SF, Cai YY, Lin K, Lindwall R, Robertson B (1998) Combined surfactant therapy and inhaled nitric oxide in rabbits with oleic acid-induced acute respiratory distress syndrome. Am J Respir Crit Care Med 158:437-443
20. Lonnqvist PA (1997) Inhaled nitric oxide in newborn and paediatric patients with pulmonary hypertension and moderate to severe impaired oxygenation: effects of doses of 3-100 parts per million. Intensive Care Med 23:773-779
21. Lindwall R, Berggren E, Blennow M, Flanby M, Frostell C, Jonsson B, Lonnkvist PA, Svensson M, Norman M (2004) Inhaled nitric oxide combined with nasal CPAP. Effects from 30 min exposure. Pediatr Res 55:507A
22. Hall RT (1999) Indications for surfactant therapy-the aAPO2 coming of age. Pediatrics 103:E25
23. Hjalmarson O (1981) Epidemiology and classification of acute, neonatal respiratory disorders. A prospective study. Acta Paediatr Scand 70:773-783
24. Moa G, Nilsson K, Zetterstrom H, Jonsson LO (1988) A new device for administration of nasal continuous positive airway pressure in the newborn: an experimental study. Crit Care Med 16:1238-1242
25. Klausner JF, Lee AY, Hutchison AA (1996) Decreased imposed work with a new nasal continuous positive airway pressure device. Pediatr Pulmonol 22:188-194
26. Huckstadt T, Foitzik B, Wauer RR, Schmalisch G (2003) Comparison of two different CPAP systems by tidal breathing parameters. Intensive Care Med 29:1134-1140
27. Merilainen PT (1990) A differential paramagnetic sensor for breath-by-breath oximetry. J Clin Monit 6:65-73
28. Fleiss JL (1986) Crossover analysis. In: Design and analysis of clinical experiments. Wiley, New York, pp 263-290
29. Stevens T, Blennow M, Soll R (2004) Early surfactant administration with brief ventilation vs selective surfactant and continued mechanical ventilation for preterm infants with or at risk for respiratory distress syndrome. Cochrane Database Syst Rev 3:CD003063
30. Sandri F, Ancora G, Bronzetti G, Capretti MG, Sciutti R, Massardo C (2004) Treatment of chronic lung disease associated pulmonary hypertension with inhaled nitric oxide administered via nasal CPAP. Pediatr Res 56:503
31. Davidson D, Barefield ES, Kattwinkel J, Dudell G, Damask M, Straube R, Rhines J, Chang CT (1998) Inhaled nitric oxide for the early treatment of persistent pulmonary hypertension of the term newborn: a randomized, double-masked, placebo-controlled, dose-response, multicenter study. The I-NO/ PPHN Study Group. Pediatrics 101:325-334
32. Kinsella JP, Walsh WF, Bose CL, Gerstmann DR, Labella JJ, Sardesai S, Walsh-Sukys MC, McCaffrey MJ, Cornfield DN, Bhutani VK, Cutter GR, Baier M, Abman SH (1999) Inhaled nitric oxide in premature neonates with severe hypoxaemic respiratory failure: a randomised controlled trial. Lancet 354:1061-1065
33. Lonnqvist PA, Jonsson B, Winberg P, Frostell CG (1995) Inhaled nitric oxide in infants with developing or established chronic lung disease. Acta Paediatr 84:1188-1192
34. Schedin U, Norman M, Gustafsson LE, Jonsson B, Frostell C (1997) Endogenous nitric oxide in the upper airways of premature and term infants. Acta Paediatr 86:1229-1235
35. Schedin U, Norman M, Gustafsson LE, Herin P, Frostell C (1996) Endogenous nitric oxide in the upper airways of healthy newborn infants. Pediatr Res 40:148-151
36. Desandes R, Desandes E, Droulle P, Didier F, Longrois D, Hascoet JM (2004) Inhaled nitric oxide improves oxygenation in very premature infants with low pulmonary blood flow. Acta Paediatr 93:66-69
37. Hu X, Cao L, Lam LK, Zhu L, Guo C, Sun B (2004) Mitigation of meconium-induced lung injury by surfactant and inhaled nitric oxide Is associated with suppression of nuclear transcription factor kappa B. Biol Neonate 87:73-81